专利检索 cpc:"A61M2230/201" 第 1 页

1.

发明公开
SYSTEMS AND METHODS FOR AUTOMATED INSULIN DELIVERY FOR DIABETES THERAPY 审中-公开

公开(公告)号：US20240350728A1

公开(公告)日：2024-10-24

申请号：US18136278

申请日：2023-04-18

申请人： Tandem Diabetes Care, Inc.

发明人： Jacob Kearns , Michael Michaud , Geoffrey A. Kruse , Thomas R. Ulrich , Paul Harris , Scott Leas , Betsy Dokken , Garrett Marin , Nicholas Sherer

IPC分类号： A61M5/172 , A61B5/145 , G16H20/17 , G16H20/60

CPC分类号： A61M5/1723 , A61B5/14532 , G16H20/17 , G16H20/60 , A61M2205/18 , A61M2205/3584 , A61M2205/3592 , A61M2205/505 , A61M2205/52 , A61M2230/201

摘要： Disclosed herein are systems and methods for mitigating the risk of insulin stacking in automated insulin delivery systems. In AID systems configured to both automatically calculate insulin delivery based on glucose levels and receive manual programming of meal boluses configured to counteract carbohydrates in a meal, insulin stacking can result if the system automatically increases insulin delivery based on a rise in glucose levels in response to consumption of a meal and the user later programs a meal bolus for the meal. The risk of such double dosing is mitigated by the systems and methods disclosed herein by enabling the system to account for recent automated insulin increases when a meal bolus is programmed.

2.

发明公开
MEDICAL DEVICE ANTENNA SYSTEMS HAVING EXTERNAL ANTENNA CONFIGURATIONS 审中-公开

公开(公告)号：US20240350727A1

公开(公告)日：2024-10-24

申请号：US18524499

申请日：2023-11-30

申请人： ABBOTT DIABETES CARE INC.

发明人： Nathan C. Crouther , Marc B. Taub , Lei He

IPC分类号： A61M5/172 , A61B5/00 , A61B5/145 , A61M5/142 , H01Q1/22 , H01Q1/27 , H01Q5/48

CPC分类号： A61M5/172 , A61B5/14532 , A61B5/6833 , A61M5/14248 , A61M5/1723 , H01Q1/2208 , H01Q1/273 , H01Q5/48 , A61M2205/3569 , A61M2205/3592 , A61M2230/201

摘要： A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surf ace of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.

3.

发明授权
Open-loop insulin delivery basal parameters based on insulin delivery records 有权

公开(公告)号：US12121700B2

公开(公告)日：2024-10-22

申请号：US17377801

申请日：2021-07-16

申请人： Insulet Corporation

发明人： James Graham , Joon Bok Lee , Jason O'Connor

IPC分类号： A61M5/00 , A61M5/172 , G16H10/60 , G16H20/17 , G16H40/67 , A61B5/00 , A61B5/145 , A61B5/1495 , A61M5/142 , A61M5/168 , G16H20/00 , G16H20/10

CPC分类号： A61M5/1723 , G16H10/60 , G16H20/17 , G16H40/67 , A61B5/00 , A61B5/0002 , A61B5/14532 , A61B5/1495 , A61B5/4836 , A61B5/4839 , A61B5/4848 , A61B5/7225 , A61B5/725 , A61B5/7275 , A61M5/142 , A61M5/14244 , A61M5/14248 , A61M5/14276 , A61M5/168 , A61M5/16877 , A61M2205/00 , A61M2205/18 , A61M2205/3561 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/8206 , A61M2230/00 , A61M2230/20 , A61M2230/201 , A61M2230/63 , G16H20/00 , G16H20/10

摘要： Disclosed are techniques and a device operable to determine a total amount of insulin delivered to the user over a predetermined time period. The total amount of insulin includes a total basal dosage delivered in basal dosages and a total bolus dosage delivered in bolus dosages over the predetermined time period. A proportion of the total amount of insulin delivered to the user provided via the total basal dosage amount over the predetermined time period is calculated. In response determining the proportion of the total amount of insulin attributed to the total basal dosage amount of insulin exceeds a threshold, an average basal dosage to be delivered within a subsequent time period that is approximately equal to the threshold may be determined. An instruction may be generated and output to deliver a modified basal dosage that substantially maintains the average basal dosage over the subsequent time period.

4.

发明授权
Integrated delivery device for continuous glucose sensor 有权

公开(公告)号：US12115357B2

公开(公告)日：2024-10-15

申请号：US17696198

申请日：2022-03-16

申请人： DexCom, Inc.

发明人： James H. Brauker , Mark A. Tapsak , Sean T. Saint , Apurv Ullas Kamath , Paul V. Neale , Peter C. Simpson , Michael Robert Mensinger , Dubravka Markovic

IPC分类号： A61M5/315 , A61B5/00 , A61B5/145 , A61B5/1486 , A61M5/172 , A61M11/00 , A61M15/00 , G16H10/40 , G16H20/17 , G16H40/63

CPC分类号： A61M5/31525 , A61B5/0002 , A61B5/14532 , A61B5/14865 , A61B5/4839 , A61M5/1723 , A61M11/00 , A61M15/0001 , G16H10/40 , G16H20/17 , G16H40/63 , A61B5/1486 , A61B2560/0443 , A61M2005/1726 , A61M2205/18 , A61M2205/3303 , A61M2205/502 , A61M2205/52 , A61M2230/201

摘要： Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.

5.

发明公开
USER INTERFACE AND SYSTEM FOR SUPPLYING GASES TO AN AIRWAY 审中-公开

公开(公告)号：US20240335632A1

公开(公告)日：2024-10-10

申请号：US18409651

申请日：2024-01-10

申请人： Fisher & Paykel Healthcare Limited

发明人： Bruce Gordon Holyoake , Dexter Chi Lun Cheung , Anil Patel , Seyed Ahmad Reza Nouraei , Milanjot Singh Assi , Thomas Heinrich Barnes , Alicia Jerram Hunter Evans , Craig Karl White , Matthew John Payton , Laith Adeeb Hermez , German Klink , Samantha Dale Oldfield , Taylor James Edwards , Aidan Robert Burgess

IPC分类号： A61M16/06 , A61M16/00 , A61M16/01 , A61M16/08 , A61M16/10 , A61M16/12 , A61M16/16 , A61M16/20 , A61M39/26

CPC分类号： A61M16/0666 , A61M16/0051 , A61M16/0066 , A61M16/0078 , A61M16/01 , A61M16/024 , A61M16/06 , A61M16/0616 , A61M16/0672 , A61M16/0858 , A61M16/0875 , A61M16/16 , A61M16/201 , A61M16/202 , A61M16/209 , A61M39/26 , A61M2016/0027 , A61M2016/0033 , A61M16/0683 , A61M16/0688 , A61M16/0816 , A61M2016/1025 , A61M2016/103 , A61M2016/1035 , A61M16/105 , A61M16/109 , A61M16/1095 , A61M16/12 , A61M16/161 , A61M16/208 , A61M2202/0208 , A61M2202/0241 , A61M2205/0216 , A61M2205/13 , A61M2205/14 , A61M2205/3303 , A61M2205/3306 , A61M2205/3317 , A61M2205/332 , A61M2205/3334 , A61M2205/3365 , A61M2205/3368 , A61M2205/3375 , A61M2205/3569 , A61M2205/3592 , A61M2205/505 , A61M2205/507 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2230/04 , A61M2230/06 , A61M2230/10 , A61M2230/201 , A61M2230/202 , A61M2230/205 , A61M2230/60 , A61M2230/63

摘要： The invention relates to a respiratory system comprising a first patient interface for delivery of a first flow of gases to a patient, a second patient interface for delivery of a second flow of gases to the patient, and a device and/or sensing arrangement that is configure to facilitate a switching of the system between a first respiratory mode where the device allowing delivery of the first flow of gases to an outlet of the first patient interface when the second patient interface is absent from the patient, and a second respiratory mode where the device reducing or stopping delivery of the first flow of gases to the outlet of the first patient interface when the second patient interface is located together with the first patient interface upon the patient.

6.

发明授权
Monitoring and communicating information using drug administration devices 有权

公开(公告)号：US12102445B2

公开(公告)日：2024-10-01

申请号：US17068865

申请日：2020-10-13

申请人： Janssen Pharmaceuticals, Inc.

发明人： Frederick E. Shelton, IV , Monica A. Kapil , Emma L. Hubert , Jason L. Harris

IPC分类号： A61B5/00 , A61B5/0205 , A61B5/11 , A61B5/145 , A61M5/172 , A61M5/20 , A61M15/00 , A61M15/08 , G16H10/60 , G16H20/10 , G16H20/30 , G16H20/40 , G16H20/60 , G16H40/20 , G16H40/40 , G16H40/67 , G16H50/30 , G16H70/40 , H04W12/02 , H04W12/0431 , A61B5/021 , A61B5/024

CPC分类号： A61B5/4839 , A61B5/0022 , A61B5/02055 , A61B5/1101 , A61B5/1112 , A61B5/1118 , A61B5/14532 , A61B5/14542 , A61B5/4266 , A61B5/4866 , A61M5/1723 , A61M5/2033 , A61M15/0065 , A61M15/08 , G16H10/60 , G16H20/10 , G16H20/30 , G16H20/40 , G16H20/60 , G16H40/20 , G16H40/40 , G16H40/67 , G16H50/30 , G16H70/40 , H04W12/02 , H04W12/0431 , A61B5/021 , A61B5/024 , A61B2560/0242 , A61M2205/3317 , A61M2205/3327 , A61M2205/3553 , A61M2205/3584 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2230/04 , A61M2230/20 , A61M2230/201 , A61M2230/50 , A61M2230/63

摘要： In general, systems and methods for monitoring and communicating information using drug administration devices are provided.

7.

发明授权
Configurable target values 有权

公开(公告)号：US12100498B2

公开(公告)日：2024-09-24

申请号：US17505867

申请日：2021-10-20

申请人： MEDTRONIC MINIMED, INC.

发明人： Benyamin Grosman , Anirban Roy , Patrick E. Weydt , Neha J. Parikh , Louis J. Lintereur , Di Wu

IPC分类号： G16H20/17 , A61B5/00 , A61B5/145 , A61M5/142 , A61M5/145 , A61M5/168 , A61M5/172 , G16H10/20 , G16H10/60 , G16H20/60 , G16H40/63 , G16H50/20 , G16H50/50 , A61K38/28 , G16H20/30 , G16H50/30

CPC分类号： G16H20/17 , A61B5/14532 , A61B5/4839 , A61M5/142 , A61M5/14244 , A61M5/145 , A61M5/16831 , A61M5/1723 , G16H10/20 , G16H10/60 , G16H20/60 , G16H40/63 , G16H50/20 , G16H50/50 , A61B5/746 , A61B5/7465 , A61K38/28 , A61M2005/14208 , A61M5/16804 , A61M5/16877 , A61M2205/18 , A61M2205/3303 , A61M2205/35 , A61M2205/3569 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/8206 , A61M2230/201 , A61M2230/63 , G16H20/30 , G16H50/30

摘要： Disclosed herein are techniques related to configurable target values. The techniques may involve identifying a target glucose value obtained based on user input. Additionally, the techniques may involve determining a fluid delivery command based on a difference between a measured glucose value and the target glucose value. The techniques may further involve causing fluid delivery by a fluid infusion device in accordance with the fluid delivery command to regulate the measured glucose value to the target glucose value.

8.

发明公开
INSULIN AND PRAMLINTIDE DELIVERY SYSTEMS, METHODS, AND DEVICES 审中-公开

公开(公告)号：US20240312591A1

公开(公告)日：2024-09-19

申请号：US18668841

申请日：2024-05-20

申请人： Ypsomed AG

发明人： Ahmad Mohamad Haidar

IPC分类号： G16H20/17 , A61B5/00 , A61B5/145 , A61K38/28 , A61M5/142 , A61M5/172 , G16H40/60

CPC分类号： G16H20/17 , A61B5/14532 , A61B5/4839 , A61K38/28 , A61M5/142 , A61M5/1723 , G16H40/60 , A61M2005/14208 , A61M2230/201

摘要： The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient.